Advertisement
YOU ARE HERE: LAT HomeCollectionsTumor
IN THE NEWS

Tumor

HEALTH
October 10, 2011 | By Michael Robinson, Los Angeles Times
There are very few specific details I remember about my experience with lung cancer, though it was just eight years ago. But there are some moments I will never forget. It has been difficult for me to put those into words; now, my words are needed only to point out a handful of scenes from the new movie "50/50" that artfully convey situations and emotions I could never quite express. It all started the summer before my senior year of high school and what seemed, at first, like a case of pneumonia that would not go away.
Advertisement
CALIFORNIA | LOCAL
September 18, 2011 | Times staff and wire reports
Kara Kennedy, the oldest child of the late Sen. Edward Kennedy, died Friday at a Washington, D.C.-area health club after her daily workout, said her brother Patrick. She was 51. "She's with Dad," said her brother, a former congressman from Rhode Island. Their father, who had a malignant brain tumor, died in 2009 at age 77 . She was diagnosed with lung cancer in 2002, and doctors removed a malignant tumor the next year. Patrick Kennedy said she loved to exercise but the cancer treatment "took quite a toll on her" and "her heart gave out. " Her mother, Joan Kennedy, told the Boston Globe that Kara's death was "such a shock because she was in such good health.
CALIFORNIA | LOCAL
August 7, 2011 | Thomas H. Maugh II, Los Angeles Times
Dr. Baruj Benacerraf, who shared the 1980 Nobel Prize in physiology or medicine for his pioneering work explaining why some people are able to fight off infections and tumors while others are not, died Tuesday at his Boston home. He was 90. The cause was pneumonia, according to the Dana-Farber Cancer Institute in Boston, where he spent most of his career. "Dr. Benacerraf's seminal discoveries about genetic control of the immune system made possible much of what we now know about basic disease processes such as infection, autoimmune disorders and cancer," Dr. Edward J. Benz Jr., president of Dana-Farber, said in a statement.
CALIFORNIA | LOCAL
August 5, 2011 | By David Zahniser and Ari Bloomekatz, Los Angeles Times
An appointee of Los Angeles Mayor Antonio Villaraigosa assigned to oversee dozens of neighborhood councils resigned after FBI agents raided his home looking for evidence that he or others downloaded child pornography. Last Friday, investigators took a computer and other evidence from the Tarzana home of Albert Abrams, who until this week had been president of the Board of Neighborhood Commissioners, a seven-member panel of mayoral appointees. Abrams, 63, submitted his resignation Wednesday and said he did not know whether he was a target of the investigation.
SPORTS
August 2, 2011 | Wire reports
Hall of Fame catcher Gary Carter received some positive news regarding his cancer treament, his daughter reported on the family website. An MRI exam revealed that Carter's brain tumors are "80 percent better," Kimmy Bloemers , Carter's daughter, wrote on the website, ESPNNewYork.com reported Tuesday. She added that there is much less swelling and the tumors are less dense. Carter is scheduled to start treatment that will require five days of chemotherapy in a pill form.
CALIFORNIA | LOCAL
July 27, 2011 | By Kim Willsher, Special to the Los Angeles Times
Reporting from Paris -- When he was diagnosed with a malignant brain tumor 20 years ago, David Servan-Schreiber, the French-born doctor, neuroscientist and later bestselling author, took the phrase "physician, heal thyself" to heart. Submitting to the punishing traditional treatments of chemotherapy and radiotherapy, he still felt there was something more he could do to enhance his chances of survival. FOR THE RECORD: An earlier version of this article incorrectly reported the name of David Servan-Schreiber's wife in the list of survivors and omitted two children.
NEWS
July 26, 2011 | By Karen Kaplan, Los Angeles Times/For the Booster Shots blog
Women with early-stage breast cancer have plenty of procedures and treatments to deal with. So it may come as welcome news that a large clinical trial has found no reason for doctors to perform two tests that were thought to help predict patient survival. Writing in the Journal of the American Medical Assn., the researchers say that the test results are meaningless. The tests in question involve looking for micrometastasis - microscopic evidence of a breast tumor's spread - in sentinel lymph nodes and in bone marrow.
NEWS
June 10, 2011 | By Thomas H. Maugh II, Los Angeles Times/For the Booster Shots blog
The Food and Drug Administration said Thursday it will require changes in the labeling of a family of drugs used to treat benign prostate hyperplasia to indicate that the drugs increase the risk of developing a more aggressive form of prostate cancer. FOR THE RECORD: A sentence in this post which said, "For use in treating prostate cancer, the FDA said, the benefits of the drugs far outweigh the risks," has been corrected to read, "For use in treating benign prostate hyperplasia, the FDA said, the benefits far outweigh the risks.
HEALTH
June 5, 2011 | By Thomas H. Maugh II, Los Angeles Times
A drug already used to treat breast cancer can reduce the risk of tumors in high- and moderate-risk post-menopausal women by 65% over a three-year period, researchers reported Saturday. Two other drugs are already approved for reducing the risk of breast tumors in healthy women: Generic tamoxifen reduces the risk by 50% over a five-year period and raloxifene (Evista) reduces the risk by 38% over a similar period. But both drugs are associated with an increased risk of potentially fatal uterine cancer and blood clots.
NEWS
June 5, 2011 | By Thomas H. Maugh II, Los Angeles Times/For the Booster Shots blog
Screening for ovarian cancer does not reduce the risk of dying from the disease but does increase the likelihood of unnecessary invasive procedures, researchers said Saturday. "We were unable to detect ovarian cancers any earlier than in the women who did not get the screening," and nearly 6% of the women tested had false positives, Dr. Christine D. Berg, chief of the early-detection branch at the National Cancer Institute told a Chicago meeting of the American Society of Clinical Oncology.
Los Angeles Times Articles
|